JAK2 and heart failure: Our findings also suggest that Epac1 and its downstream pathway, including Jak2 or STAT3, may be an attractive target for treatment of cardiac failure in sepsis, and possibly cardiac failure in general, since cytokine-induced cardiac dysfunction plays an important role in the pathogenesis of cardiac failure [21].